MeVis Medical Solutions AG Revises Current Fiscal Year Forecast

• MeVis Medical Solutions AG is adjusting its annual forecast for the fiscal year 2023/2024 based on preliminary business figures.
• Expected sales for the fiscal year are now projected to be stable between €17.0 million and €17.5 million, down from a previous forecast of €18.0 million to €18.5 million.
• EBIT is anticipated to decline to between €3.0 million and €3.5 million, compared to the earlier forecast of stability in the range of €4.5 million to €5.0 million.
• The decline in sales is attributed to cautious purchasing behavior due to global economic challenges.
• The company's results will also be significantly affected by the fluctuations in the US dollar/euro exchange rate since the beginning of the fiscal year.
• The announcement was made on September 4, 2024, and is in compliance with Article 17 MAR of the Regulation (EU) No 596/2014.

The price of MeVis Medical Solutions at the time of the news was 22,800EUR and was down -6,17 % compared with the previous day.

MeVis Medical Solutions

+0,87 %

-0,85 %

-8,66 %

-12,12 %

-23,68 %

-28,40 %

-20,00 %

-54,40 %

ISIN:DE000A0LBFE4WKN:A0LBFE

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• Max